Objectives: To evaluate the incidence of a distinct multidrug-resistant (MDR) grouping of Salmonella serotype Typhimurium strains carrying the hybrid virulence resistance plasmid pUO-StVR2, and its possible evolution in the region where it was first detected [Principality of Asturias (PA), Spain].
Introduction
Salmonella enterica serotype Typhimurium (S. Typhimurium) is one of the most common bacteria causing food-borne disease in developed countries. 1 As with many other non-typhoid serotypes, infection usually results in self-limited gastroenteritis, which does not require antimicrobial therapy. However, bacteria can occasionally be invasive, and even fatal, particularly for patients with underlying risk factors, such as immunosuppression. In these cases, effective antimicrobial therapy is necessary. A wide diversity of virulence (V) factors have been described for Salmonella, and they can be located on the bacterial chromosome, frequently as part of pathogenicity islands, on plasmids and prophages. [2] [3] [4] The V plasmid of S. Typhimurium (pSLT) has a size of 94 kb, belongs to the incompatibility group IncFII and contains the spvABCDR locus (responsible for an increase in the bacterial growth rate in mice during the systemic phase of disease), the pefBACDI operon (for biosynthesis of fimbriae involved in adherence to the intestinal epithelium) and the rck and rsk genes (resistance to complement killing), in addition to genes encoding for essential plasmid functions (such as plasmid replication and maintenance). 4, 5 S. Typhimurium LT2 (the type strain of Typhimurium) is susceptible to antimicrobial drugs, as were the majority of Salmonella strains circulating until the 1980s. Since then, multidrug-resistant (MDR) groupings have emerged and, nowadays, isolates pertaining to them are far more frequent than drugsusceptible isolates. 1, 6 A MDR clone, defined as S. Typhimurium 
DT104
, with resistance (R) to ampicillin, chloramphenicolflorfenicol, streptomycin-spectinomycin, sulphonamides and tetracyclines (AMP-CHL-STR-SUL-TET phenotype), was initially detected in animals and later in humans. Today it is widely spread and could be considered as pandemic. 1, 6, 7 In this MDR clone, the genes encoding the five antimicrobial-R [bla PSE-1 -floR-aadA2-sul1-tet(G)] are located within a chromosomal island (SGI1), with different variants reported over time, which include two class 1 integrons (designated as InC:1200 bp/bla PSE-1 and InD:1000 bp/aadA2) described as In4-type integrons. 6, 8 In 1997, a new MDR grouping that is monophasic [4,(5) ,12:i:-] appeared in Spain. 9 In general, it displays gentamicin-R and trimethoprim-R, in addition to the DT104 pentaresistant phenotype, with the R genes located on large plasmids carrying a class 1 integron (InI:1900 bp/ dfrA12-aadA2). In 2002, our laboratory characterized 12 MDR clinical S. Typhimurium isolates collected during 1993-2000 in the Principality of Asturias (PA), Spain. 10 They had the same R phenotype as the pentaresistant DT104 associated to a different R genotype [bla OXA-1 -catA1-[strA/B-aadA1a]-[sul1-sul2]-tet(B)], with two of the genes pertaining to a distinctive integron (InH:2000 bp/bla OXA-1 -aadA1a). The R genotype was conferred by pUO-StVR2, a hybrid self-transferable plasmid, apparently derived from pSLT. These isolates generated a common and distinctive XbaI macrorestriction profile and could be considered as clonally related. Recently, it was established that the bla OXA gene present in pUO-StVR2 was in fact bla OXA-30 that differs from bla OXA-1 by only 1 nt (GenBank accession number AY534545).
When pUO-StVR2 was first described, 10 it was already highlighted that the coexistence of virulence and resistance genes in the same extrachromosomal element represents a serious threat for human health that deserves epidemiological surveillance. In the present work we aimed to follow the impact on human health of the S. Typhimurium clone carrying pUO-StVR2 during 2001-02, and to ascertain its possible evolution in the region where this hybrid plasmid was first detected. 
Materials and methods

Bacterial isolates
Antimicrobial susceptibility
Antimicrobial susceptibility was tested according to NCCLS guidelines 12 by a disc-diffusion technique using commercial discs (bioMérieux and Oxoid). The antimicrobials and quantities in micrograms tested were: ampicillin (AMP), 10; aztreonam (ATM), 30; cefotaxime (CTX), 30; ceftazidime (CAZ), 30; chloramphenicol (CHL), 30; co-amoxiclav (AMC), 30; gentamicin (GEN), 10; nalidixic acid (NAL), 30; spectinomycin (SPT), 10; streptomycin (STR), 10; sulfadiazine (SUL), 300; tetracycline (TET), 30; and trimethoprim (TMP), 5.
PCR procedures and DNA sequencing
Single and multiple PCRs, using specific primers and conditions previously described, 10, [13] [14] [15] [16] were performed for detection of V-pSLT genes (spvC, rck, pefA and pefC), V chromosomal genes (iroB, phoP/Q, agfA, stn, slyA, invE/A, sopE1 and sefD), R genes [bla OXA, bla PSE, bla TEM, catA1, strA/B, aadA1a, sul1, sul2, tet(B), dfrA1 and dfrA12] and Class 1 integrons. Primers for other pSLT and chromosomal V genes were designed for the present work:
For a correct description of the type of bla OXA gene carried by pUOStVR2/InH, the 708 bp amplicons obtained with the bla OXA primers 13 from LSP 31/93 and LSP 153/02 were sequenced. In both cases the gene was identified as bla . Confirmation of the insertion of bla OXA-30 and aadA1a into the 2000 bp amplicons generated with the 5 0 CS/3 0 CS primers was achieved by nested-PCR, using the 2000 bp amplicon as the template DNA, and primers specific for the bla OXA and aadA1a genes. 17 
Plasmid analysis and Southern hybridization
Plasmid DNA was routinely purified by the method of Kado and Liu. 18 However, for a better resolution of large plasmids with a similar size, plasmid extraction from selected isolates was also performed by S1-PFGE. 19 Plasmids ranging in size from 7 to 150 kb extracted from Escherichia coli 39R861 (NCTC 50192) and l Ladder PFG Marker (New England BioLabs) were used as molecular size standards for undigested and S1-digested DNA, respectively. Selected plasmid profiles were sequentially hybridized with probes specific for spvC, bla OXA-30 and dfrA12. The probes were obtained from LT2 (spvC), LSP 31/93 (bla ) and LSP 174/01 (dfrA12) by PCR amplification using DIG-labelled dNTPs (PCR DIG labelling mix; Roche Applied Science), followed by gel extraction and purification with the GFX TM DNA and Gel Band Purification Kit (Amersham Biosciences).
Genomic macrorestriction-PFGE analysis S. Typhimurium isolates were analysed by macrorestriction and PFGE. Slices of the DNA-containing plugs were subjected to XbaI (Takara Biomedicals, 30 U; 4 h at 37 C) and BlnI (Takara Biomedicals, 20 U; overnight at 37 C) digestion. A CHEF-DRIII system (Bio-Rad Laboratories) was used to separate the fragments under the standardized conditions recommended by 'The Salm-gene project'. 20 The LT2 isolate was used as PFGE marker. 21 Similarity between XbaI-BlnI profiles was evaluated by the Jaccard's coefficient (S), and cluster analysis was performed by the unweighted pair group method with arithmetic averages, using the software program MVSP (Multivariate Statistics Package for PCs, RockWare Inc.). Strains showing profiles with similarity coefficients of ‡0.70 were considered members of the same cluster. Regarding ampicillin, 182 (73.4%) out of the 248 S. Typhimurium isolates were resistant. All of them were tested for the presence of three bla genes and for In profile by PCR procedures. Results showed that 91, 37 and 49 isolates generated the expected amplicons for bla PSE (419 bp), bla TEM (503 bp) and bla OXA (708 bp), respectively, while in the remaining five, the ampicillin-R determinants were not identified. In addition, 151 isolates were Inpositive, and could be differentiated into four In profiles, In-P1 (1200 + 1000 bp); In-P2 (1900 -150 bp); In-P3 (2000 bp); and In-P4 (1600 bp), with 91, 10, 49 and 1 isolate(s), respectively. Both traits, bla gene and In profile, together with the antigenic formula, were used to discriminate the isolates into three major groupings: G1 (bla PSE , In-P1), G2 (bla TEM , In-P2) and G3 (bla OXA , In-P3), apart from other, as yet undefined, groupings ( Table 1) . The presence of bla OXA and the aadA1a gene within the 2000 bp amplicon characteristic of In-P3 (InH) was confirmed by nested-PCR amplification using specific primers for each gene (not shown).
Results
S. Typhimurium ampicillin resistance in the Principality of Asturias
Characterization of G3 isolates
The 49 isolates belonging to G3 and the control strains LT2 and LSP 31/93 were tested for the presence of pSLT determinants, No., number of isolates; NI, not identified; NT, non-typeable; RDNC, reaction does not conform. plasmid profile, resistance profile (RP) and virulence profile (VP). All these, as well as the control LSP 31/93 strain, were spvC-, rckand parA/B-positive and pefABCD-negative, and carried a plasmid of the size expected for pUO-StVR2 (140 kb; readily visualized after extraction by the Kado and Liu method). In addition, some G3 isolates contained one or more plasmids of smaller size and unknown function (data not shown). As expected, G3 isolates showed the RP conferred by pUO-StVR2, but one of them (LSP 174/01) was also trimethoprim-R. PCR amplification revealed that dfrA12 was the gene responsible for such resistance (not shown). Plasmid extraction from this and several other isolates (LSP 31/93, LSP 238/02 and LT2) by S1-PFGE, followed by Southern hybridizations, demonstrated that, together with pUO-StVR2, a plasmid of 110 kb (labelled pUO-StR12) was present in LSP 174/01, and the dfrA12 mapped on it (Figure 1a and d) . In contrast, the bla OXA and spvC probes mapped on the 140 kb plasmid from the G3 isolates (LSP 31/93 and LSP 238/02) and the second also on the 94 kb plasmid from LT2 (Figure 1b and c) .
To further characterize the isolates belonging to G3, they were analysed for VP. Results revealed that all of them, as well as the control strains, were positive for the genes used as indicators of five Salmonella pathogenicity islands (invE/A and orgA, SPI1; ttrC and ssaQ, SPI2; mgtC and misL, SPI3; spi4R and spi4D, SPI4; and sopB and pipA, SPI5). In addition, they were also positive for seven out of nine other V genes tested (phoP/Q, agfA, slyA, stn, iroB and sodCI). However, all were negative for sefD and all except LT2 were also negative for sopE1.
Dispersion of pUO-StVR2 between genomic types of S. Typhimurium
By XbaI-macrorestriction PFGE analysis the clinical isolates could be discriminated into five XbaI profiles (X1-X5), with most isolates (85.7%) belonging to X1 and X2. LSP 31/93, the G3 strain from the previous period, generated the X1 profile while LT2 gave a distinct profile, here termed X0 (Table 2 and Figure 2a) . Total DNA from representative isolates of the different XbaI profiles (6, 6, 1, 1 and 2 belonging to X1-X5, respectively; Table 2 ), and the controls LSP 31/93 and LT2, were also analysed by BlnI macrorestriction (Figure 2b ). In general, results obtained with the second endonuclease matched those obtained with XbaI. In fact, all except one of the isolates tested with BlnI could be assigned to the B0-B5 profiles, which corresponded to the X0-X5 profiles. The exception was LSP 174/01 (dfrA12-positive) that generated the X2 profile but a distinct BlnI profile, termed B6 (Table 2 and Figure 2b ), which differed from B2 by the presence of an additional 110 kb fragment (probably corresponding to pUO-StR12). The XbaI and BlnI profiles were combined, and a dendrogram of similarity was constructed (Figure 2c) . At a cut-off point of S = 0.73 all profiles from pUO-StVR2 isolates fall into a single cluster, which was related to LT2 at S = 0.54. It is interesting to note that the newly described profiles differed from the earliest X1-B1 by 2-6 bands. Moreover, the two combined profiles that included most of the analysed isolates (X1-B1 and X2-B2) differed only by three bands. Accordingly, the G3 grouping appears to be highly clonal. 22 
Discussion
Using two genetic markers, type of bla gene and In profile, three well-defined MDR groupings (G1-G3), together with other not well-defined groupings of S. Typhimurium could be distinguished as a cause of human salmonellosis in the PA over the period 2001-02. As in other countries, 23 the pentaresistant DT104 clone (here defined as G1: bla PSE , InC:1200 bp and InD:1000 bp), was the most frequent. It was involved in at least 89 salmonellosis episodes associated with 91 clinical isolates [89 collected from faeces and two from patients suffering from bacteraemia secondary to gastroenteritis (with positive blood and faeces cultures)]. They represented 6.4 and 36.7% of the S. enterica and S. Typhimurium clinical isolates recorded in the LSP, respectively. The second most frequent grouping was G3, identified as positive for bla OXA , InH:2000 bp (containing the bla OXA -aadA1a gene cassettes) and pUO-StVR2. It was implicated in at least 44 sporadic episodes including 47 isolates, and one family outbreak (here represented by two isolates with the same macrorestriction The 49 clinical isolates and the control LSP 31/93 were positive for the R genes bla OXA , catA1, strA/B, aadA1a, sul1/l2 and tet(B). S, susceptible to antimicrobials; RP1, all pUO-StVR2 resistance determinants; RP2, RP1 and dfrA12 positive.
b
All were positive for the V genes spvC, rck, iroB, phoP/Q, agfA, stn, slyA, sodCI, invE/A, orgA, ttrC, ssaQ, mgtC, misL, spi4R, spi4D, sopB, pipA and parA/B. VP1, all V-pSLT and V chromosome genes tested except sefD; VP2, all V genes tested except pefABCD, sefD and sopE1. profiles). Apart from the outbreak, 38 sporadic episodes were of gastroenteritis (two isolates were collected at different days from the same patient, and showed different phage type: DT104 and DT193). The remaining four corresponded to bacteraemia, and isolates with identical traits were recovered from both blood and ascitic fluid in one patient, and from blood and faeces in the other three. The 49 G3-isolates represented 3.4 and 19.7% of S. enterica and S. Typhimurium, respectively, recorded at the LSP during 2001-02. A third MDR grouping, G2, corresponding to the [4,(5) ,12:i:-] variant (here identified as positive for bla TEM and InI:1900 bp -In0:150 bp) was related to 10 sporadic episodes of gastroenteritis, representing 0.7 and 4.0% of S. enterica and serotype Typhimurium, respectively. It should be kept in mind that the actual frequency of salmonellosis and of the three major ampicillin-R groupings in the PA could be much higher, since in intestinal disease episodes, only some people require hospital attention, and, usually, Salmonella organisms are only collected from them. In addition, not all the isolates collected in the PA Microbiology Laboratories are forwarded to the LSP. It is of note that direct information about the distribution of G3 in places other than the PA is not available. However, recent studies from different Spanish laboratories have demonstrated the presence of InH:2000 bp/bla OXA -aadA1a integrons in isolates of S. Typhimurium, [24] [25] [26] although its relation with hybrid plasmids has not been investigated, or could not be demonstrated. Noteworthy, one of the analysed isolates yielded a PFGE profile similar to X1. 25 In studies from four other European countries (Albania, Italy, Portugal and Norway), MDR plasmids carrying InH-type integrons were reported in S. Typhimurium. The Albanian isolates, which were associated with sporadic cases of acute gastroenteritis in children, carried self-transferable R plasmids of 140 kb, belonging to the incompatibility group IncFI, and conferring the AMP-CHL-KAN-STR-SUL-TMP -TET MDR phenotype. 27 More recently, a bla OXA -containing integron was found in the virulence plasmid of an MDR S. Typhimurium strain collected in Italy. 28 This plasmid, apparently non-conjugative, was of 110 kb in size, conferred the AMP-GEN-KAN-STR-SPT-SUL-TMP phenotype, and belonged to the incompatibility group IncFII. The Portuguese isolates, 29 recovered from humans and pork, carried InH-type integrons on self-transferable plasmids (reported as >70 kb and showing different restriction profiles), which encoded the AMP-STR-SUL-TET -CHL R phenotype. These isolates generated XbaI profiles similar to X1 and X2 found in the PA isolates. Finally, bla OXA -aadA1 integrons were also detected in four AMP-CHL-STR-SUL-TET strains from patients hospitalized in Norway. 30 Interestingly, although one of the strains was reported as domestically acquired, the remaining three were acquired in Spain.
With respect to virulence, V determinants common to LT2 and G3 included 10 chromosomal genes representing the 5 SPIs as well as 6 non-SPI located genes (phoP/Q, agfA, slyA, stn and iroB) [31] [32] [33] [34] [35] and the bacteriophage-associated sodCI gene. 36 However, the sopE1 gene was present in LT2 but not in pUO-StVR2-positive isolates. This gene, located on a temperate bacteriophage, encodes an effector protein of the SPI1 type III secretion system, which contributes to host cell invasion and intestinal inflammation in animal models. 37 As expected, LT2 and G3 isolates were negative for sefD, a gene of the sef operon, which encodes the SEF18 fimbriae in Salmonella Enteritidis. 16, 32 With respect to plasmid genes, all G3 isolates contained spvC, rck, parA and parB but lacked the pef operon, while LT2 was positive for all these genes. According to this, deletions in the pef operon could have occurred when the R region was inserted into pSLT to originate the hybrid plasmid. Such a possibility is currently being investigated.
It is interesting to note that 12 G3 isolates, collected during 1993-2000, and previously subjected to PFGE analysis, showed a single XbaI profile (X1). 10 In contrast, the 49 isolates recovered over 2001-02 generated five XbaI profiles (X1-X5), although >85% belonged to X1 and X2. Comparisons of these, and the corresponding BlnI profiles, supported that most G3 isolates are clonally related. Accordingly, vertical transmission could be the main way for the spread of pUO-StRV2, although horizontal transfer of the plasmid cannot be ruled out. In fact, the observed polymorphisms on the genomic DNA, together with the different phage types, the different plasmid profiles and the acquisition of a new trimethoprim-R determinant (dfrA12), are compatible not only with the evolution of the progeny of an original G3 strain, but also with the transfer of the plasmid to relatively related S. Typhimurium strains. Further epidemiological surveillance will be required to determine the potential of a wider distribution of the emergent MDR cluster carrying pUO-StRV2.
